Feb 25, 2025 4:01pm EST HeartBeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock
Feb 13, 2025 8:31am EST HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock
Jan 29, 2025 8:31am EST HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software
Dec 16, 2024 8:31am EST HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
Nov 19, 2024 8:31am EST HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
Oct 31, 2024 8:31am EDT HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time
Oct 24, 2024 8:31am EDT HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards
Oct 17, 2024 8:31am EDT HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization